Genvor

Biotechnology Research • United States • 1-10 Employees

Company overview

Headquarters	United States
Website	genvor.com
NAICS	541714
Keywords	Research And Development And Agriculture, Food Security Innovation, Sustainable Crop Protection, Ai-Accelerated Peptide Discovery, Aflatoxin Prevention, Bio-Stimulant Solutions, Cross-Crop Scalability, Peptide Platform Technology, Residue-Free Agriculture, Usda Collaboration
Founded	2018
Employees	1-10
Socials

Key Contacts at Genvor

Lance Culnane

Director Of Ai & Machine Learning

Jesse Jaynes

Chairman & Co-Founder

Chad Pawlak

Chief Executive Officer

Genvor Email Formats

Genvor uses 1 email format. The most common is {first name} (e.g., john@genvor.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@genvor.com	100%

About Genvor

Genvor, Incorporated (OTCQB: GNVR) leverages its patented AI-accelerated peptide platform to develop sustainable, residue-free agricultural solutions that are designed to optimize crop performance across row and specialty crops. Our approach addresses agriculture’s most critical needs: enhanced productivity, regulatory compliance, and consumer safety. • Cross-crop scalability transforming single discoveries into multi-crop opportunities • Our peptides support multiple formulation approaches – biological integrations, transgenic seed traits, and bio-active applications. • Capital-light, licensing-first model designed for scalable, efficient market entry and growth

Genvor revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$425,000